Development of a Clioquinol Nanocarrier as a New, Promising Option for the Treatment of Dermatomycosis
Dermatomycosis is a common fungal infection, and its treatment is limited by few antifungal agents. Clioquinol (CQ) is an antiparasitic agent that has been studied for new uses, such as antifungal and antiviral applications. CQ was incorporated into a lipid-based nanocarrier as a new, promising opti...
Saved in:
Main Authors: | Simone Jacobus Berlitz (Author), Paula Reginatto (Author), Gabriella da Rosa Monte Machado (Author), Alexandre Meneghello Fuentefria (Author), Fernando Dal Pont Morisso (Author), Renata Vidor Contri (Author), Irene Clemes Külkamp-Guerreiro (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoemulsion Containing Kojic Dipalmitate and Rosehip Oil: A Promising Formulation to Treat Melasma
by: Júlia Capp Zilles, et al.
Published: (2023) -
Epidemiological Characterization of Dermatomycosis in Ethiopia
by: Araya S, et al.
Published: (2021) -
NQO1 protects against clioquinol toxicity
by: Jamuna Chhetri, et al.
Published: (2022) -
Conventional and molecular diagnostics for detection of causative fungi in clinical samples of human dermatomycosis
by: Khaled M Tawfik, et al.
Published: (2022) -
Experience Professional dermatomycosis of the face, neck and upper part of chest caused by T. mentagrophytes
by: O. V. Matveeva, et al.
Published: (2021)